An interventional study of Molli Suit Apply in Mollii Suit and Cerebral Palsy, sponsored by Kırıkkale University. Recruiting at 1 site in Turkey. Open to participants aged 4 Years to 18 Years. Per ClinicalTrials.gov, last updated 2024-03-12.
Sponsored by Kırıkkale University · Not applicable, Interventional, and Treatment
The aim of our study is to examine the acute effect of Mollii Suit application on balance and muscle tone problems in children with spastic cerebral palsy.
Cerebral Palsy (CP) is the most common developmental disorder in childhood. Individuals' independence in daily living activities and participation in education, games, social and community activities are restricted. Technology applications in the field of rehabilitation are gaining momentum. EXOPULSE Mollii Suit method, one of the newest rehabilitation technology products, is a non-invasive neuromodulation approach with a garment that covers the whole body and electrodes placed inside. Designed to improve motor function by reducing spasticity and pain, the method is based on the principle of reciprocal inhibition, which occurs by stimulating the antagonist of a spastic muscle at low frequencies and intensities. Therefore, the aim of our study is to examine the acute effect of Mollii Suit application on balance and muscle tone problems in children with spastic cerebral palsy.
750 studies on the registry are indexed under Paralysis; 133 are open to participants now.
This study's planned enrollment of 30 is close to the median of 30 across 537 interventional studies indexed under Paralysis.
Browse Paralysis studies →Kırıkkale University is the lead sponsor of 112 studies on the registry; 25 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Evaluations will be made before the children are dressed in the Mollii Suit, and the evaluations will be repeated after the children are dressed and practiced for 60 minutes.
Other: Molli Suit Apply
Evaluations will be made before the children are dressed in the Mollii Suit, and the evaluations will be repeated after the children are dressed and applied for 60 minutes with the device in off mode.
Other: Molli Suit Apply
Children will be evaluated and the evaluations will be repeated 60 minutes later.
Exopulse Mollii Suit is a neuromodulation application that has been extensively evaluated and is a reliable technique in patients with spasticity. Unlike many neurostimulation techniques that focus only on symptomatic muscles, Suit relieves spasticity and associated pain by stimulating the weakened antagonist of the spastic muscle. Its wearable structure is designed to manage spasticity and associated pain in both upper and lower extremities.
Gross Motor Function Classification System (GMFCS)
Gross Motor Function Classification System (GMFCS) developed by R. Palisano will be used in the classification of motor function.
Time frame: 1 Minute
Modified Tardiue Scale (MTS)
The MTS assesses the muscle's response to stretch at given velocities.
Time frame: 5 minutes
Modifiye Modified Ashworth Scale (MAS)
The modified Ashworth scale (MAS), has been applied in clinical practice and research as a measure of spasticity. The modified Ashworth scale purpose is to grade muscle spasticity.
Time frame: 5 Minutes
NMC Tests with Seansamove Sensbalance
NMC Tests means Neuro Muscular Control tests, and it consists of a number of fully adjustable balance tests. The software calculates up to what point the person is able to perform within the outlines of the exercise, and it will give a score per test. The tests and their duration can be adjusted. Individually applicable and very handy. Once it is adjusted, the same test can be repeated by just pushing a button. Time and results are easy to compare with previous tests.
Time frame: 5 minutes
Plan to share: No
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kırıkkale University